The canister should be discarded after the labeled number of actuations have been used. The amount of medication in each actuation cannot be assured after this point. Store between 59 ° F (15 ° C) and 86 ° F (30 °C). Avoid excessive humidity. For optimal results, the canister should be at room temperature before use. Shake well before using. Note: The indented statement below is required by the Federal government's Clean Air Act for all products containing or manufactured with chlorofluorocarbons (CFCs): Warning Contains trichloromonofluoromethane (CFC-11), dichlorodifluoromethane (CFC-12) and dichlorotetrafluoroethane (CFC-114), substances which harm public health and the environment by destroying ozone in the upper atmosphere. A notice similar to the above Warning has been placed in the information for the patient of this product under the Environmental Protection Agency's (EPA's) regulations. The patient's warning states that the patient should consult his or her physician if there are any questions about alternatives. Manufactured by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, USA Ipratropium bromide licensed from: Boehringer Ingelheim International GmbH © Copyright Boehringer Ingelheim Pharmaceuticals, Inc. 2001, ALL RIGHTS RESERVED | ||||
Email this article
Printer friendly
Bookmark this pageadvertisement
